Replacement Heart Valves
Edwards Lifesciences boosts valve manufacturing in Singapore
Edwards Lifesciences (NYSE:EW) doubled a heart valve manufacturing facility in Singapore, saying it needs the boost to keep up with growing demand for tissue heart valves.
TV’s Dr. Oz joins Medtronic TAVI lawsuit | MassDevice.com On Call
Medtronic claims a win in European patent row with Edwards Lifesciences
Medtronic’s CoreValve skips FDA panel review on path to U.S. market
TCT 2013: Medtronic’s new CoreValve U.S. trial results bode well for 2014 approval
TCT 2013: St. Jude Medical’s Portico valve looks good at 30 days
TCT 2013: Higher pacemaker rate marks difference between Medtronic’s, Edwards Lifesciences’ TAVI devices
TCT 2013: Is TAVI cost-effective in operable patients?
TCT 2013: Medtronic unveils full 1-year results from ADVANCE CoreValve trial
Boston Scientific wins CE Mark for Lotus TAVI
Boston Scientific (NYSE:BSX) said it won CE Mark approval in the European Union for its Lotus transcatheter aortic valve implant.
The Lotus device was put on the market as soon as the approval came through, Natick, Mass.-based Boston Scientific said.